Guided self-help based on CBT principles : For those with less severe presentations, structured self-help programmes with support from a healthcare professional can be effective and are more readily accessible
Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity (GID-TA11544)
Many clients notice a boost in energy, mental clarity, and focus within hours to a few days of their first injection
Status: Recruiting Double-blinded randomized clinical trial investigating the effects of subcutaneous semaglutide vs placebo on alcohol consumption in 108 patients diagnosed with alcohol use disorder and comorbid obesity over a 26-week period
This guide explains why RUO labeling is not enough for GLP-1 products, what has changed in the legal landscape, and what companies should consider before continuing or entering this market
Originally developed to help manage type 2 diabetes, GLP-1 drugs stimulate the body to produce more insulin when blood sugar levels start to rise